Navigation Links
Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
Date:11/10/2011

IRVINE, Calif., Nov. 10, 2011 /PRNewswire/ -- Shands Jacksonville Medical Center and Masimo (NASDAQ: MASI) today jointly announce the conversion of Shands Jacksonville Medical Center to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities.  The conversion equips the acute care hospital, which also operates one of the biggest and busiest trauma centers, with the most technologically and clinically-advanced pulse oximetry technology—shown to have the best specificity (lowest rate of false alarms) and sensitivity (highest true alarm detection)—and noninvasive patient monitoring solutions that allow clinicians to measure multiple blood constituents, fluid responsiveness, respiration rate, and other physiological parameters without invasive blood sampling and time-consuming laboratory analysis.(1-2)  

"Converting to Masimo rainbow® SET provides our clinicians with superior patient monitoring capabilities and advanced clinical measurements that offer more immediate access to a higher quality of clinical data at the point-of-care," said Dr. Michael Nussbaum, Chair of the University of Florida College of Medicine Department of Surgery at Shands Jacksonville. "Our evaluations of available pulse oximetry technology led us to the decision to standardize on Masimo's technology platform not only because it during motion and low perfusion, but because it also provides additional noninvasive blood, fluid and respiration capabilities that other oximeters can't—providing our clinicians with the clinical intelligence they need to deliver an exceptional level of care and safety to our patients."

Masimo rainbow® SET Pulse CO-Oximetry is a breakthrough technology platform that allows hosp
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Prescription Assistance Arrives in Jacksonville, Florida
2. Free Dog Heart Checks in Jacksonville
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... BEVERLY HILLS, Calif. , Jan. 14, 2014 The Brandeis ... Los Angeles a premier and affordable laser tattoo ... treatment special. Dr. Brandeis, focus is in providing high quality cosmetic ... to all patients. " Southern California ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , Inc., ... its Innovation Leadership Summit , May 14-16, 2014 ... Cleveland Ohio . This ... organizations committed to breakthrough achievements through open innovation. Participants ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... 2014 By discovering a new mechanism that allows ... researchers at UC Irvine and the Salk Institute have ... or prevent stroke-induced brain damage. , A complex and ... death and primary reason for disability in the U.S. ... and lets blood-borne material into the brain, causing the ...
(Date:4/17/2014)... international team led by researchers at UC Davis has ... a key role in cell division, also boosts the ... first time the complex has been shown to perform ... an excellent target to control cellular energy production, potentially ... published online today in the journal Developmental Cell ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... National Institutes of Health today announced the release of ... affect as many as 70 million Americans each year. ... of the National Commission on Digestive Diseases describes the ... and liver failure, and maps out priorities for research ...
... to make anti-cancer drug paciltaxel. , , ... , , , ... , , , ... , , , , EAST LANSING, Mich. --- Research by ...
... , April 2 Immtech Pharmaceuticals, Inc. (NYSE AMEX: ... 2009, the Company received notice from the NYSE Amex LLC ... to delist the Company,s common stock. The Company intends ... the Exchange,s listing qualifications panel. Pursuant to Exchange rules, ...
... both doctors and patients , , THURSDAY, April 2 ... federal government spell out the differences between available treatments ... , The guides, produced by the Agency for Healthcare ... insulin analogues to conventional insulin (human insulin). The guides ...
... 2 In a press conference today, Colgate and,the ... la Salud,Bucal: Un Mundo de Sonrisas Saludables (Oral Health ... ongoing commitment to quality oral care among the,Hispanic community. ... and lack of familiarity accessing oral,healthcare services, among other ...
... Aurora Health Care has appointed ... M.D., as vice president of cancer services. (Logo: ... from St. Jude Children,s Research Hospital in Memphis, ... physician relations and domestic affiliates. Prior to that, ...
Cached Medicine News:Health News:NIH releases the first research plan to reduce the burden of digestive diseases 2Health News:NIH releases the first research plan to reduce the burden of digestive diseases 3Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 2Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 3Health News:Immtech Receives Listing Determination Letter 2Health News:Plain-Language Guides Detail Insulin Treatments 2Health News:Colgate and the Hispanic Dental Association Proclaim April El Mes de la Salud Bucal to Promote Oral Health Fundamentals Among Hispanics 2Health News:Colgate and the Hispanic Dental Association Proclaim April El Mes de la Salud Bucal to Promote Oral Health Fundamentals Among Hispanics 3Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 2Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 3